Champions Oncology, Inc.
US ˙ NasdaqCM ˙ US15870P3073

SecurityCSBR / Champions Oncology, Inc.
InstitutionTocqueville Asset Management L.p.
Latest Disclosed Ownership608,915 shares
Ownership 4.40%
Tocqueville Asset Management L.p. ownership in CSBR / Champions Oncology, Inc.

2025-02-14 - Tocqueville Asset Management L.p. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 608,915 shares of Champions Oncology, Inc. (US:CSBR). This represents 4.4 percent ownership of the company. In their previous filing dated 2024-02-12 , Tocqueville Asset Management L.p. had reported owning 684,578 shares, indicating a decrease of -11.05 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date		Effective
Date		Form Prev
Shares		 Latest
Shares		 ΔShares
(Percent)		 Ownership
(Percent)		 ΔOwnership
(Percent)
2025-02-14 2025-02-14 13G/A 684,578 608,915 -11.05 4.40 -12.00
2024-02-12 2024-02-12 13G 684,578 5.00

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F CHAMPIONS ONCOLOGY COM NEW 15870P307 319,674 0 0.00 1,838 -16.76 0.0273
2026-02-12 2025-12-31 13F CHAMPIONS ONCOLOGY COM NEW 15870P307 319,674 0 0.00 2,209 6.72 0.0322
2025-11-13 2025-09-30 13F CHAMPIONS ONCOLOGY COM NEW 15870P307 319,674 -80,208 -20.06 2,070 -29.79 0.0301
2025-08-12 2025-06-30 13F CHAMPIONS ONCOLOGY COM NEW 15870P307 399,882 0 0.00 2,947 -15.07 0.0449
2025-05-13 2025-03-31 13F CHAMPIONS ONCOLOGY COM NEW 15870P307 399,882 -209,033 -34.33 3,471 -33.50 0.0567
2025-02-10 2024-12-31 13F CHAMPIONS ONCOLOGY COM NEW 15870P307 608,915 -96,299 -13.66 5,218 51.95 0.0818
2024-11-08 2024-09-30 13F CHAMPIONS ONCOLOGY COM NEW 15870P307 705,214 20,586 3.01 3,434 -2.97 0.0539
2024-08-12 2024-06-30 13F CHAMPIONS ONCOLOGY COM NEW 15870P307 684,628 0 0.00 3,540 5.52 0.0584
2024-05-09 2024-03-31 13F CHAMPIONS ONCOLOGY COM NEW 15870P307 684,628 50 0.01 3,355 -12.82 0.0548
2024-02-12 2023-12-31 13F CHAMPIONS ONCOLOGY COM NEW 15870P307 684,578 19,150 2.88 3,847 -6.90 0.0697
2023-11-09 2023-09-30 13F CHAMPIONS ONCOLOGY COM NEW 15870P307 665,428 0 0.00 4,132 -2.66 0.0785
2023-08-11 2023-06-30 13F CHAMPIONS ONCOLOGY COM NEW 15870P307 665,428 0 0.00 4,245 58.69 0.0760
2023-05-10 2023-03-31 13F CHAMPIONS ONCOLOGY COM NEW 15870P307 665,428 50,200 8.16 2,675 -3.57 0.0505
2023-02-09 2022-12-31 13F CHAMPIONS ONCOLOGY COM NEW 15870P307 615,228 273,562 80.07 2,775 8.27 0.0527
2022-11-10 2022-09-30 13F CHAMPIONS ONCOLOGY COM NEW 15870P307 341,666 55,055 19.21 2,562 11.73 0.0522
2022-08-12 2022-06-30 13F CHAMPIONS ONCOLOGY COM NEW 15870P307 286,611 34,150 13.53 2,293 11.69 0.0419
2022-05-16 2022-03-31 13F Champions Oncology COM 15870P307 252,461 0 0.00 2,053 -2.75 0.0310
2022-02-14 2021-12-31 13F CHAMPIONS ONCOLOGY COM NEW 15870P307 252,461 0 0.00 2,111 -18.11 0.0290
2021-11-15 2021-09-30 13F CHAMPIONS ONCOLOGY COM NEW 15870P307 252,461 0 0.00 2,578 -0.66 0.0382
2021-08-16 2021-06-30 13F CHAMPIONS ONCOLOGY COM NEW 15870P307 252,461 0 0.00 2,595 -9.04 0.0375
2021-05-17 2021-03-31 13F CHAMPIONS ONCOLOGY COM NEW 15870P307 252,461 0 0.00 2,853 4.74 0.0439
2021-02-16 2020-12-31 13F CHAMPIONS ONCOLOGY COM NEW 15870P307 252,461 0 0.00 2,724 16.66 0.0455
2020-11-16 2020-09-30 13F CHAMPIONS ONCOLOGY COM 15870P307 252,461 0 0.00 2,335 -3.27 0.0447
2020-08-12 2020-06-30 13F CHAMPIONS ONCOLOGY COM NEW 15870P307 252,461 0 0.00 2,414 29.23 0.0503
2020-05-15 2020-03-31 13F CHAMPIONS ONCOLOGY COM 15870P307 252,461 47,893 23.41 1,868 9.62 0.0464
2020-01-14 2019-12-31 13F Champions Oncology COM 15870P307 204,568 70,000 52.02 1,704 124.21 0.0251
2019-10-31 2019-09-30 13F Champions Oncology COM 15870P307 134,568 55,000 69.12 760 21.99 0.0103
2019-07-31 2019-06-30 13F Champions Oncology COM 15870P307 79,568 0 0.00 623 -20.03 0.0081
2019-04-30 2019-03-31 13F Champions Oncology COM 15870P307 79,568 0 0.00 779 25.44 0.0104
2019-02-08 2018-12-31 13F Champions Oncology COM 15870P307 79,568 -10,000 -11.16 621 -60.32 0.0093
2018-11-13 2018-09-30 13F Champions Oncology COM 15870P307 89,568 -25,383 -22.08 1,565 114.68 0.0197
2018-08-13 2018-06-30 13F Champions Oncology COM 15870P307 114,951 114,951 729 0.0092
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.